BioSpace News Archive

COVID-19 refers to a viral infection occurred due to a corona virus named SARS-CoV-2. This virus attacks the respiratory tract of an individual.

The key CSO appointment of Dr. Hogaboam will elevate the company’s research and development of new therapeutic applications for the treatment of fibrotic diseases and conditions.

Global WholeHealth Partners Corp (OTC: GWHP), a multinational supplier of over 70+ FDA Approved Diagnostic Tests, attains breakthrough on rising neurological disease.

Eli Lilly and Company announced that Diogo Rau will join the company on May 17, 2021 as senior vice-president and chief information and digital officer.

Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), today announced additional positive pre-clinical results in its immuno-oncology program demonstrating efficacy of its live biotherapeutic product (LBP) consortium BMC128, this time in melanoma. In these studies,

HealthPoint Plus, a leading telehealth provider today announced the production release of its StepUp™ HomeLab.

Antech Diagnostics, part of Mars Veterinary Health, released new data showing that all cats from a retrospective review of 730,000 veterinary visits received improved preventive care following a positive or negative RenalTech™, which predicts chronic kidney disease in cats 2 years before it occurs.

Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2021 after the market closes on Tuesday, April 20, 2021 , and will host a conference call at 5:30 p.m. ET that day to discuss those results.

908 Devices (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced that Michele Fournier has joined the company as Chief People Officer. Bringing more than thirty years of global human resources experience in corporate and consulting roles

Castle Biosciences Announces Prospective, Multi-Center Publication Demonstrating DecisionDx ® -Melanoma as Significant, Independent Predictor of Patient Outcomes in Cutaneous Melanoma Study published in JCO Precision Oncology